AS
RPRX icon

Altshuler Shaham’s Royalty Pharma RPRX Stock Holding History

Altshuler Shaham’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-933
Closed -$25.3K – 306
2023
Q3 		$25.3K Sell
933
-146
-14% -$4.34K ﹤0.01% 201
2023
Q2 		$33.2K Sell
1,079
-129
-11% -$4.37K ﹤0.01% 212
2023
Q1 		$43.5K Buy
+1,208
New +$44.8K ﹤0.01% 198
2022
Q4 		– Sell
-885
Closed -$36K – 579
2022
Q3 		$36K Buy
885
+178
+25% +$7.6K ﹤0.01% 286
2022
Q2 		$30K Buy
+707
New +$29K ﹤0.01% 317

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Altshuler Shaham's RPRX Position: Q4 2023 in Review

Altshuler Shaham sold out of Royalty Pharma (RPRX) in Q4 2023, closing a stake of 933 shares — an estimated $25.3K sold.

Altshuler Shaham first reported a position in RPRX in Q2 2022 and held it in 5 quarters. The position peaked at $43.5K in Q1 2023. 363 funds tracked by Wall St. Rank hold RPRX as of Q4 2023.

  • Altshuler Shaham reported no remaining Royalty Pharma position as of Q4 2023 after selling out during the quarter.
  • Altshuler Shaham sold 933 Royalty Pharma shares in Q4 2023, an estimated $25.3K.
  • Altshuler Shaham first reported a position in Royalty Pharma in Q2 2022 and held it in 5 quarters.
  • Altshuler Shaham's Royalty Pharma position peaked at $43.5K in Q1 2023.
  • 363 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2023.

Based on Altshuler Shaham's 13F filing for Q4 2023, filed 7 Feb 2024.